PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12551918-4	2003	Although both p42/44 MAPK and p38 MAPK were activated rapidly in cells stimulated with BzATP, only pharmacological inhibition of p38 MAPK attenuated O(2)(-)* production.	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate	87-92	mitogen-activated protein kinase 14	Mus musculus	30-38	
17306762-2	2007	ATP (1 mM) and the P2X7R agonist BzATP (100 microM) significantly increased p38 MAPK phosphorylation in WT mice, and these effects were absent in the hippocampal slices of P2X7R(-/-) mice.	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate	33-38	mitogen-activated protein kinase 14	Mus musculus	76-84	
29501771-9	2018	Finally, we observed that P2 x 7R agonist BzATP reversed the inhibition effect of GRGM-13 on RGC-5 cell apoptosis, ROS level and p-p38 expression, while si-P2 x 7R inhibited oxidative stress-induced phosphorylation of p38.	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate	42-47	mitogen-activated protein kinase 14	Mus musculus	131-134	
29501771-9	2018	Finally, we observed that P2 x 7R agonist BzATP reversed the inhibition effect of GRGM-13 on RGC-5 cell apoptosis, ROS level and p-p38 expression, while si-P2 x 7R inhibited oxidative stress-induced phosphorylation of p38.	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate	42-47	mitogen-activated protein kinase 14	Mus musculus	218-221	
17306762-3	2007	Both ATP- and BzATP-induced p38 MAPK phosphorylations were sensitive to the p38 MAP kinase inhibitor, SB203580 (1 microM).	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate	14-19	mitogen-activated protein kinase 14	Mus musculus	28-36	
17306762-3	2007	Both ATP- and BzATP-induced p38 MAPK phosphorylations were sensitive to the p38 MAP kinase inhibitor, SB203580 (1 microM).	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate	14-19	mitogen-activated protein kinase 14	Mus musculus	76-90